Retinal ganglion cells (RGCs) can develop tau-linked pathology in neurodegenerative disorders, including Alzheimer's disease, progressive supranuclear palsy, and corticobasal degeneration. Because the retina is accessible to non-invasive imaging, tau-associated RGC injury is a candidate biomarker for disease staging and monitoring.
Retinal ganglion cells (RGCs) can develop tau-linked pathology in neurodegenerative disorders, including Alzheimer's disease, progressive supranuclear palsy, and corticobasal degeneration. Because the retina is accessible to non-invasive imaging, tau-associated RGC injury is a candidate biomarker for disease staging and monitoring.
Overview
Mermaid diagram (expand to render)
RGCs are projection neurons whose axons form the optic nerve and transmit visual signals to central targets.[@sanes2015] In tauopathy contexts, RGC dysfunction reflects both local retinal stress and systems-level neurodegenerative processes involving axonal transport, neuroinflammation, and synaptic injury.[@stamelou2023][@calkins2012]
RGC Biology Relevant To Tauopathy
Structure And Function
RGC somas reside in the ganglion cell layer, with dendrites in the inner plexiform layer and long myelinated axons extending to thalamic and midbrain nuclei.[@sanes2015] Their long axons and high metabolic demand make them sensitive to cytoskeletal and mitochondrial injury.[@calkins2012][@osborne2017]
Molecular Markers
Common RGC-associated markers include BRN3A/BRN3B, RBPMS, and neurofilament proteins; these are frequently used in imaging-pathology correlation studies.[@sanes2015][@nadalnicols2014]
Tauopathy Features In Retinal Ganglion Cells
Pathological Signatures
Studies report hyperphosphorylated tau epitopes (for example AT8/PHF1-reactive species), dystrophic neurites, and reduced RGC layer thickness in AD-spectrum cohorts.[@den2017][@london2013] Similar 4R-tau-driven processes are biologically plausible in PSP/CBD, where shared tau mechanisms can involve visual and oculomotor circuits.[@stamelou2023][@dickson2010]
Mechanistic Cascade
Tau misfolding and phosphorylation in vulnerable neurons[@stamelou2023][@wang2016]
Somatodendritic tau accumulation and transport disruption[@wang2016][@alavi2013]
Synaptic and mitochondrial stress in RGC compartments[@calkins2012][@osborne2017]
Progressive axonal degeneration in optic pathways[@london2013][@alavi2013]
Diagnostic And Translational Applications
Imaging Biomarkers
Optical coherence tomography (OCT), OCT angiography, and advanced retinal imaging provide quantitative readouts (RNFL/GCL thickness, microvascular metrics) that can track neurodegenerative change longitudinally.[@london2013][@lim2016]
Clinical Utility
Retina-based readouts are attractive because they are repeatable, scalable, and potentially sensitive to early neurodegenerative changes before severe disability.[@lim2016][@chan2019]
Therapeutic Relevance
RGC tauopathy can be used as a pharmacodynamic window for therapies targeting tau phosphorylation, tau propagation, mitochondrial dysfunction, and neuroinflammation.[@stamelou2023][@calkins2012] Integrating retinal biomarkers with tau PET and fluid biomarkers may improve monitoring in CBS/PSP trials.[@dickson2010][@chan2019]